Imprint
Content
Dr. Erkens Consulting Group
Industriestraße 13
D- 64380 Roßdorf
Germany
Tel: +49 6154 – 69 67 944 • Mobil +49 179 – 2 41 10 29
Message to Dr. Erkens Consulting Group
tax no. 73 841 210 966
Webmaster
be-sign.net • Bernd Scheurer
Mainstr. 2, 64390 Erzhausen
Tel.: +49 151 – 50 411 034
Message to Webmaster
Web: www.be-sign.net
Scripting
Stefan Klose
(M.Sc. Informatik)
Copyrights
Unless otherwise stated, the copyright of the photos used lies with Dr. Erkens Consulting Group.
The corresponding statutory provisions apply to all registered brands, trade names and logos used on our website, even if they are not marked as such in the respective places.
- Photo Home: ABWI74/pixabay
- Photo Business area Strategie | Consulting: Headway/unsplash
- Photo Business area Management | Leadership: Marten van den Heuvel/unsplash
- Photo Business area Analyses | Market research: Carlos Muza/unsplash
- Photo Business area Marketing | Sales: Diggity Marketing/unsplash
- Photo Business area Communication | Education: Marko Pekić/unsplash
- Photo News: Andrys/pixabay
- Photo Company: Dagobert1980/pixabay
- Photo: Meeting: jmexclusives/pixabay
- Photo: Microscope: kkolosov/pixabay
- Photo Services: paulbr74/pixabay
- Photo Network: StockSnap/pixabay
- Photo Academy: plugrafico/pixabay
- Photo Blog: Free-Photos/pixabay
- Photo: Career: rolandmey/pixabay
- Photo Contact: Skitterphoto/pixabay
- Photo MediaCenter: JESHOOTS-com/pixabay
- Photo GTC, Imprint, Privacy: Cleverpix/pixabay
Adress
Dr. Erkens Consulting Group
Industriestraße 13
64380 Roßdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de
Social
News
Dr. Erkens Consulting Group
- Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020 - Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020
Pharma Letter
- SunRock and Escugen unite on first-in-class ADC for tough tumors
- BioTroy takes in $28 million to move novel cancer drug forward
- AbbVie’s atogepant achieves superiority in migraine prevention
- Mineralys enhances lorundrostat data package ahead of planned NDA
- Key findings of EY’s annual Biotech Beyond Borders Report 2025
Pharma Relations
Pharma Times
- Teva and Fosun Pharma partner on early-stage oncology drug
- FDA approves UroGen’s Zusduri to treat recurrent bladder cancer
- EDX medical partners with spire healthcare to advance disease diagnostics
- Investigational treatment shows promise for aggressive multiple myeloma
- Levicept presents new LEVI-04 data at EULAR
PZ online
- Adipositas: Chips und Schoko verändern ruckzuck das Gehirn
- Reisedurchfall: Urlaub mit Nebenwirkung
- Kammerpräsident Christiansen: »Historische Chance für den Berufsstand«
- Lachgas, K.-o.-Tropfen: ABDA fordert Regeln zur Altersprüfung
- Beschluss des GB-A: Kostenloses Lungenkrebs-Screening für starke Raucher
Our Place on Earth
Kartenbild: OpenStreetMap, ODbL 1.0